Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers P > Headlines for Pharmacyclics, Inc. > News item |
Rodman & Renshaw initiates Pharmacyclics coverage at market outperform
Pharmacyclics Inc. coverage was initiated by Rodman & Renshaw, LLC analyst Matthew N. Murray with a market outperform rating and a $22 price target. Shares of the Sunnyvale, Calif.-based pharmaceutical company were up $0.29, or 3.96%, at $7.61 on volume of 201,481 shares versus the three-month running average of 143,291 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.